BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28363124)

  • 1. Structural principles controlling HIV envelope glycosylation.
    Behrens AJ; Crispin M
    Curr Opin Struct Biol; 2017 Jun; 44():125-133. PubMed ID: 28363124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer.
    Behrens AJ; Harvey DJ; Milne E; Cupo A; Kumar A; Zitzmann N; Struwe WB; Moore JP; Crispin M
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV glycan shield as a target for broadly neutralizing antibodies.
    Doores KJ
    FEBS J; 2015 Dec; 282(24):4679-91. PubMed ID: 26411545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.
    Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H
    J Virol; 2017 May; 91(9):. PubMed ID: 28202756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational Heterogeneity of the HIV Envelope Glycan Shield.
    Yang M; Huang J; Simon R; Wang LX; MacKerell AD
    Sci Rep; 2017 Jun; 7(1):4435. PubMed ID: 28667249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
    Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles.
    Hargett AA; Wei Q; Knoppova B; Hall S; Huang ZQ; Prakash A; Green TJ; Moldoveanu Z; Raska M; Novak J; Renfrow MB
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsecond Dynamics and Network Analysis of the HIV-1 SOSIP Env Trimer Reveal Collective Behavior and Conserved Microdomains of the Glycan Shield.
    Lemmin T; Soto C; Stuckey J; Kwong PD
    Structure; 2017 Oct; 25(10):1631-1639.e2. PubMed ID: 28890362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1.
    Behrens AJ; Struwe WB; Crispin M
    Expert Rev Proteomics; 2017 Oct; 14(10):881-890. PubMed ID: 28870097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 envelope glycan moieties modulate HIV-1 transmission.
    Shen R; Raska M; Bimczok D; Novak J; Smith PD
    J Virol; 2014 Dec; 88(24):14258-67. PubMed ID: 25275130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer.
    Gristick HB; Wang H; Bjorkman PJ
    Acta Crystallogr D Struct Biol; 2017 Oct; 73(Pt 10):822-828. PubMed ID: 28994411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of the HIV-1 Env glycan shield across scales.
    Berndsen ZT; Chakraborty S; Wang X; Cottrell CA; Torres JL; Diedrich JK; López CA; Yates JR; van Gils MJ; Paulson JC; Gnanakaran S; Ward AB
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28014-28025. PubMed ID: 33093196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.
    Stewart-Jones GB; Soto C; Lemmin T; Chuang GY; Druz A; Kong R; Thomas PV; Wagh K; Zhou T; Behrens AJ; Bylund T; Choi CW; Davison JR; Georgiev IS; Joyce MG; Kwon YD; Pancera M; Taft J; Yang Y; Zhang B; Shivatare SS; Shivatare VS; Lee CC; Wu CY; Bewley CA; Burton DR; Koff WC; Connors M; Crispin M; Baxa U; Korber BT; Wong CH; Mascola JR; Kwong PD
    Cell; 2016 May; 165(4):813-26. PubMed ID: 27114034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer.
    Sarkar A; Bale S; Behrens AJ; Kumar S; Sharma SK; de Val N; Pallesen J; Irimia A; Diwanji DC; Stanfield RL; Ward AB; Crispin M; Wyatt RT; Wilson IA
    Nat Commun; 2018 May; 9(1):1956. PubMed ID: 29769533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein.
    Behrens AJ; Vasiljevic S; Pritchard LK; Harvey DJ; Andev RS; Krumm SA; Struwe WB; Cupo A; Kumar A; Zitzmann N; Seabright GE; Kramer HB; Spencer DI; Royle L; Lee JH; Klasse PJ; Burton DR; Wilson IA; Ward AB; Sanders RW; Moore JP; Doores KJ; Crispin M
    Cell Rep; 2016 Mar; 14(11):2695-706. PubMed ID: 26972002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.
    Zhou T; Doria-Rose NA; Cheng C; Stewart-Jones GBE; Chuang GY; Chambers M; Druz A; Geng H; McKee K; Kwon YD; O'Dell S; Sastry M; Schmidt SD; Xu K; Chen L; Chen RE; Louder MK; Pancera M; Wanninger TG; Zhang B; Zheng A; Farney SK; Foulds KE; Georgiev IS; Joyce MG; Lemmin T; Narpala S; Rawi R; Soto C; Todd JP; Shen CH; Tsybovsky Y; Yang Y; Zhao P; Haynes BF; Stamatatos L; Tiemeyer M; Wells L; Scorpio DG; Shapiro L; McDermott AB; Mascola JR; Kwong PD
    Cell Rep; 2017 Apr; 19(4):719-732. PubMed ID: 28445724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.